Impairment of the nitrite oxide/cyclic GMP pathway in cerebellar slices prepared from the hph-1 mouse

Brain Research

Volumn 735, Issue 1, 1996, Pages 169-172

  Brand, M P ^a   Briddon, A ^b   Land, J M ^a,b   Clark, J B ^a   Heales, S J R ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

cGMP; hph 1 mouse; Kainate; Nitric oxide; Tetrahydrobiopterin

Indexed keywords

CYCLIC GMP; KAINIC ACID; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; S NITROSOGLUTATHIONE; TETRAHYDROBIOPTERIN; 5,6,7,8-TETRAHYDROBIOPTERIN; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; BIOPTERIN; DRUG DERIVATIVE; ENZYME INHIBITOR; GLUTATHIONE; N(G) NITROARGININE; NITROSO DERIVATIVE; OXYHEMOGLOBIN; PENICILLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CEREBELLUM; CONTROLLED STUDY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CBA MOUSE; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; MUTATION; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; ANTIOXIDANTS; BIOPTERIN; CEREBELLUM; CYCLIC GMP; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTATHIONE; KAINIC ACID; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, MUTANT STRAINS; MUTATION; NITRIC OXIDE; NITROARGININE; NITROSO COMPOUNDS; ORGAN CULTURE TECHNIQUES; OXYHEMOGLOBINS; PENICILLAMINE; PLATELET AGGREGATION INHIBITORS; S-NITROSO-N-ACETYLPENICILLAMINE; S-NITROSOGLUTATHIONE;

EID: 0030606932     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00892-X     Document Type: Article

References (27)

1. [1] Blau, N., Thony, B., Heizmann, C.W. and Dhondt, J.-L., Tetrahydrobiopterin deficiency: from phenotype to genotype, Pteridines, 4 (1993) 1-10.
2. [2] Brand, M.P., Heales, S.J.R., Land, J.M. and Clark, J.B., Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the hph-1 mouse, J. Inher. Metab. Dis., 18 (1995) 33-39.
3. [3] Brand, M.P., Hyland, K., Engle, T., Smith, I. and Heales, S.J.R., Neurochemical effects following peripheral administration of tetrahydropterin derivatives to the hph-1 mouse, J. Neurochem., 66 (1996) 1150-1156.
4. [4] Bredt, D.S., Glatt, C.E., Hwang, P.M., Fotuhi, M., Dawson, T.M. and Snyder, S.H., Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase, Neuron, 7 (1991) 615-624.
5. [5] Bush, P.A., Gonzalez, N.E., Griscavage, J.M. and Ignarro, L.J., Nitric oxide synthase from cerebellum catalyses the formation of equimolar quantities of nitric oxide and citrulline from L-arginine, Biochem. Biophys. Res. Commun., 185 (1992) 960-966.
6. [6] Garthwaite, J., Charles, S.L. and Chess-Williams, R., Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain, Nature, 336 (1988) 385-388.
7. [7] Garthwaite, J., Southam, E. and Anderton, M., A kainate receptor linked to nitric oxide synthesis from arginine, J. Neurochem., 53 (1989) 1952-1954.
8. [8] Garthwaite, J., Glutamate, nitric oxide and cell-cell signalling in the nervous system, Trends Neurosci., 14 (1991) 60-67.
9. [9] Honoré, T., Davies, S.N., Drejer, J., Fletcher, E.J., Jacobsen, P., Lodge, D. and Nielsen, F.E., Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists, Science, 241 701-703.
10. [10] Howells, D.W., Smith, I. and Hyland, K., Estimation of tetrahydrobiopterin and other pterins in cerebrospinal fluid using reversed phase HPLC with electrochemical detection, J. Chromatogr., 381 (1986) 285-294.
11. [11] Hyland, K. and Bola, F., Tetrahydrobiopterin and biogenic amine status of the hph-I mouse mutant, Biol. Chem. Hoppe-Seyler, 370 (1989) 387.
12. [12] Hyland, K. and Engle, T., Tyrosine hydroxylase deficiency in the hph-I mouse: does tetrahydrobiopterin regulate the steady state concentration of the aromatic amino acid hydroxylases? (Abstr 41). In Tenth International Symposium Chemistry and Biology of Pteridines and Folates, University of South Alabama, Orange Beach, AL, p. 63.
13. [13] Ichinose, H., Ohye, T., Takahashi, E., Seki, N., Hori, T., Segawa, M., Nomura, Y., Endo, K., Tanaka, H., Tsuji, S., Fujita, K. and Nagatsu, T., Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene, Nature Genet., 8 (1994) 236-242.
14. [14] Kaufman, S., Tetrahydrobiopterin and hydroxylation systems in health and disease. In W. Lovenburg and R.A. Levine (Eds.), Unconjugated Pterins in Neurobiology: Basic and Clinical Aspects, Taylor and Francis, London, 1987, pp. 1-28.
15. [15] Kaufman, S., New tetrahydrobiopterin dependent systems, Annu. Rev. Nutr., 13 (1993) 261-286.
16. [16] Leeming, R.J., Pheasant, A.E. and Blair, J.A., The role of tetrahydrobiopterin in neurological disease, J. Ment. Def. Res., 25 (1981) 231-241.
17. [17] Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall and R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
18. [18] McDonald, J.D. and Bode, V.C., Hyperphenylalaninaemia in the hph-1 mouse mutant, Pediatr. Res., 23 (1988) 63-67.
19. [19] McDonald, J.D., Cotton, R.G.H., Jennings, I., Ledley, F.D., Woo, S.L.C. and Bode, V.C., Biochemical defect of the hph-1 mouse mutant is a deficiency in GTP cyclohydrolase activity, J. Neurochem., 50 (1988) 655-657.
20. [20] Mayer, B., John, M., Heinzel, B., Werner, E.R., Wachter, H., Schulz, G. and Böhme, E., Brain nitric oxide synthase is a biopterin-and flavin-containing multi-functional oxido-reductase, FEBS Lett., 288 (1991) 187-191.
21. [21] Murphy, M.E. and Noack, E., Nitric oxide assay using hemoglobin method, Methods Enzymol., 233, 240-250.
22. [22] Smith, I. and Brenton, D.P., Hyperphenylalaninaemias. In K. Tada and N.R.M. Buist (Eds.), Inborn Metabolic Diseases, Diagnosis and Treatment, Springer-Verlag, Heidelberg, 1995, pp. 147-160.
23. [23] Southam, E., East, S.J. and Garthwaite, J., Excitatory amino acid receptors coupled to the nitric oxide/cyclic GMP pathway in rat cerebellum during development, J. Neurochem., 56 (1991) 2072-2081.
24. [24] Southam, E. and Garthwaite, J., The nitric oxide-cyclic GMP signalling pathway in rat brain, Neuropharmacology, 32 (1993) 1267-1277.
25. [25] Stuehr, D.J., Kwon, N.S., Nathan, C.F., Griffith, O.W., Feldman, P.L. and Wiseman, J., N-Hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine, J. Biol. Chem., 266, 6259-6263.
26. [26] Tayeh, M.A. and Marletta, M.A., Macrophage oxidation of L-arginine to nitric oxide, nitrite and nitrate. Tetrahydrobiopterin is required as a cofactor, J. Biol. Chem., 264 (1989) 19654-19658.
27. [27] Williams, A.C., Levine, R.A., Chase, T.N., Lovenburg, W. and Calne, D.B., CSF hydroxylase cofactor levels in some neurological diseases, J. Neurol. Neurosurg. Psychiatry, 43 (1980) 735-738.